Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Irinotecan generic?

See the DrugPatentWatch profile for Irinotecan

What irinotecan generic products are on the market?

“Irinotecan generic” usually refers to lower-cost versions of irinotecan hydrochloride (the active ingredient used in cancer chemotherapy). The generic name is typically shown on prescriptions as irinotecan (often with the salt form such as irinotecan hydrochloride) and is marketed under different brand/generic label names depending on the manufacturer and country.

If you tell me your country (or the exact product strength you’re looking for, like 20 mg/mL vs 100 mg/5 mL), I can narrow down which irinotecan generics are most commonly available there.

How can I check who makes irinotecan generics and whether patents are still active?

You can use DrugPatentWatch.com to look up patent/exclusivity status tied to specific irinotecan products and track challenges/filings where available: DrugPatentWatch – Irinotecan (search)

What’s the difference between “irinotecan” and “liposomal irinotecan” (Onivyde)?

Some searches for “irinotecan generic” actually target liposomal irinotecan, which is a different formulation than standard irinotecan and is sold under brand names (for example, Onivyde in the US for liposomal irinotecan). Standard irinotecan generics are not interchangeable with liposomal irinotecan because the drug product and dosing/clinical use differ.

If you share whether you mean standard irinotecan or liposomal irinotecan, I can tailor the answer.

Will a generic irinotecan work the same as the brand?

In general, a generic should have the same active ingredient and is expected to meet regulatory requirements for equivalence (so it should work the same way clinically). But patients still may see differences in:
- formulation details (e.g., excipients),
- dosing schedules based on the specific protocol,
- and handling requirements (typical for IV chemotherapy).

If you share the exact label you’re comparing (brand name + strength), I can help you interpret whether it’s standard irinotecan or liposomal irinotecan.

What side effects are patients asking about with irinotecan (including generics)?

Common irinotecan-associated side effects include:
- diarrhea (sometimes delayed),
- nausea and vomiting,
- low white blood cell counts (neutropenia),
- fatigue,
- abdominal cramping,
- fever with infection risk when counts are low,
- hair thinning.

If you’re asking because of a specific symptom, tell me what’s happening and the timing relative to the infusion.

Can generics enter before patent expiry?

Sometimes generics enter the market while patents or exclusivity remain active, depending on patent status, regulatory pathways (like challenge outcomes), and litigation. Patent and exclusivity details are product- and jurisdiction-specific, so checking the specific irinotecan product on DrugPatentWatch.com is the fastest way to confirm current status: DrugPatentWatch – Irinotecan (search)

---

Quick question so I can be precise

Are you looking for standard IV irinotecan or liposomal irinotecan (Onivyde-type), and what country are you in?



Other Questions About Irinotecan :

Is Irinotecan effective for CRC?